Full-Time

Commissioning Engineer - Mechanical

Multiple Teams

CAI

CAI

1,001-5,000 employees

Operational readiness consulting for pharma

Compensation Overview

₹400.1k - ₹1.7M/yr

India

In Person

Relocation to client sites is a prerequisite; must be willing to travel domestically and internationally.

Bachelor's

Category
Mechanical Engineering (2)
,

Get referred to CAI

See people who can refer or advise you

Requirements
  • BE/BTech in Mechanical Engineering
  • 3 to 8 years or more of experience in testing, commissioning and qualification jobs
  • Excellent oral and written communication skills in English
  • Able to travel domestically and internationally, as and when required
  • Relocation to Client sites is a prerequisite
Responsibilities
  • Commissioning, safe work practices, facility turnover, and issue resolution as part of the Commissioning Engineers responsibilities.
  • Develop and execute the commissioning tests to demonstrate to the customer that vendor equipment is correctly installed and set to work.
  • Support enhanced design reviews and consult on submission of LEED qualification packages.
  • Main tasks include protocol writing and execution, FATs SATs, walk downs and development of summary reports at the client site.
  • Develop and QA/QC of all mechanical test procedures, MOPS, SOOs and checklists.
  • Assist with vendor coordination and management.
  • Perform equipment inspection to ensure build adherence to vendor submittal.
  • QA/QC of mechanical equipment installation/startup.
  • Develop reports for the mechanical testing and contribute to a daily report to the Commissioning Project Manager.
  • Execute test scripts to confirm equipment and system operation to design specification.
  • Support and perform design specification review, manufacturer submittals, one line drawing sets, and project schedule documentation.
  • Ensure safe work practices are followed by the commissioning team and customer site.
  • Primarily working for India region commissioning projects.
  • Expected to support other Data Centre/Building commissioning projects in other global regions.
  • This job description is not all inclusive and you may be asked to do other duties related to the CAI projects.

CAI Technical Consulting Malaysia SDN (cagents.com) delivers operational readiness consulting for pharmaceutical, biotechnology, and healthcare clients to prepare for full-scale production. It works by conducting operational readiness assessments and then providing tailored implementation plans that cover project planning, production operations, asset management, reliability, and sustainability, plus specialized services like Digital Pathology Validation for Leica Biosystems. The firm differentiates itself through active industry collaboration, ongoing professional development, and a global, hands-on approach that pairs quick assessments with practical, cost-effective solutions. Its goal is to help clients achieve operational excellence and successful scale-up by delivering ready-to-deploy strategies and compliant processes.

Company Size

1,001-5,000

Company Stage

Pre-seed

Total Funding

$3.4M

Headquarters

Indianapolis, Indiana

Founded

1996

Get referred to CAI

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CAI closed JLL recapitalization on July 1, 2026, funding hiring, technology, and acquisitions.
  • JLL's July 2026 news archive signals active platform-building across calibration and surface-science services.
  • Australia expansion and new technology partnerships broaden CAI's customer base beyond North America.

What critics are saying

  • CAI now faces JLL's growth targets; failed integration of tuck-ins will crush margins by 2027.
  • Operational-readiness work depends on client capex; delayed FDA, data-center, and factory builds hit revenue fast.
  • A failed recapitalization or acquisition spree turns CAI into a fragmented services roll-up by 2028.

What makes CAI unique

  • CAI spans commissioning, qualification, validation, and operational readiness across regulated facilities.
  • JLL Partners cited CAI's global footprint and 30-year reputation in mission-critical environments.
  • Fedegari partnership links CAI directly to sterilization technology from procurement through operation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

100% Employee Owned

24 Days PTO/5 Sick days per year + Additional Holidays depending on Country

Medical / Dental / Vision (In accordance with each countries’ applicable regulations)

Professional Development (Approximately $5,000 paid career-related, continuing education)

ESOP/401k – 15% Company Contribution

Company Paid Long-Term Disability

Company Paid Life Insurance

Company Paid Parental Leave (In accordance with each countries’ applicable regulations)

Other Benefits Depending on Country

Growth & Insights and Company News

Headcount

6 month growth

4%

1 year growth

4%

2 year growth

4%
PR Newswire
May 5th, 2026
JLL Partners backs CAI to expand life sciences and mission-critical services globally

CAI, a professional services firm specialising in operational readiness for life sciences and mission-critical environments, has agreed to a partnership with New York-based private equity firm JLL Partners to support its next growth phase. The investment will enable CAI to expand its global presence, invest in advanced technologies and enhance its service offerings. The company, which has operated for over 30 years, employs more than 700 professionals across North America, Europe, Australia and Asia. JLL Partners managing director Vikas Mouli cited CAI's reputation for launching cutting-edge facilities with precision and reliability. The transaction has signed definitive documentation but has not yet closed, pending regulatory approvals. CAI specialises in commissioning, qualification and validation services for highly regulated environments, helping organisations deploy complex facilities, systems and technologies.

PR Newswire
May 5th, 2026
CAI Launches Next Chapter with Investment from JLL Partners

/PRNewswire/ -- CAI, a professional services firm dedicated to accelerating operational readiness and excellence in life sciences and mission-critical...

Business Wire
May 22nd, 2024
Cai And Fedegari Group Forge Strategic Partnership To Deliver Transformational Turnkey Sterilization Solutions To Pharmaceutical Manufacturers

INDIANAPOLIS--(BUSINESS WIRE)--CAI, a global company that provides technical, operational consulting, and project management services, today announced its strategic partnership with Fedegari Group, a manufacturer and service provider of high-performance sterilization systems. This partnership will elevate steam sterilization capabilities for companies spanning the life sciences and biotech industries. The goal of the partnership is to improve the application of steam sterilization science and minimize sterilization process implementation time, in order to reduce lifecycle costs, lower cost of goods, as well as streamline manufacturing processes. According to the terms of the partnership, Fedegari and CAI will integrate their offerings to provide a seamless experience from procurement to operation. In addition, the partners will cooperate on developing and validating state-of-the-art sterilization technology, driving science-based sterilization process and protecting both sensitive products and process equipment. "Fedegari is a world leader in providing aseptic manufacturing solutions, without operator intervention to produce advanced sterile products

PR Newswire
Jul 10th, 2023
Impact Of Training On Operational Readiness, Upcoming Webinar Hosted B

Xtalks Life Science Webinars. . His wide-ranging expertise and experience will be integral to the discussion, particularly regarding the development and implementation of successful training programs

PR Newswire
Apr 27th, 2023
Supply Chain Strategies For 2023, Upcoming Webinar Hosted By Xtalks

The ability to obtain medical commodities, raw materials, even transport and equipment is slowly beginning to normalize — that is to the ‘new’ normal, not at pre-pandemic levels. .